EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

High-dose vitamin C supplementation in patients undergoing allogeneic hematopoietic stem cell transplantation: A pilot randomized, triple-blind, placebo-controlled trial

Shima Heidari, Bita Shahrami, Soroush Rad, Kourosh Sadeghi, Leyla Sharifi Aliabadi, Molouk Hadjibabaei, Mohammad Vaezi

Supportive Care in Cancer · 2026-03 · 34 (3)

DOI: 10.1007/s00520-026-10434-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 16.02.2026. Verfasst von Shima Heidari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Antioxidants, Ascorbic Acid, Hematopoietic Stem Cell Transplantation, Vitamins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Allogenic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for hematological disorders but often results in micronutrients deficiency and complications. Vitamin C, a potent antioxidant, may improve endothelial function, tissue protection, and immune recovery. This study evaluated the effects of early high-dose vitamin C supplementation on plasma vitamin C levels and post-HSCT complications. METHODS: In this pilot, triple-blind, placebo-controlled trial, 31 adult allo-HSCT patients were randomized to receive intravenous vitamin C (50 mg/kg/day) or placebo from day + 1 to + 14, followed by oral vitamin C (500 mg/day) or placebo until day + 100. Plasma vitamin C levels were measured at days 0, + 7, + 15, and discharge. Patients were monitored for post-HSCT complications until day + 100. RESULTS: Plasma vitamin C levels were significantly higher in the vitamin C group at all time points (P < 0.001). Trends toward reduced acute graft-versus-host disease (33% vs. 44%), lower oral mucositis severity (46.6% vs. 62.5%), and shorter duration (7.5 ± 3.6 vs. 9.1 ± 3.7 days) were observed, though not statistically significant. No significant adverse events were reported. CONCLUSION: High-dose vitamin C effectively corrected plasma levels, and while trends toward reduced complications were observed in allo-HSCT patients, larger trials are needed to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsAscorbic AcidHematopoietic Stem Cell TransplantationVitaminsAdultAgedFemaleHumansMaleMiddle AgedYoung AdultAdministration, OralDietary SupplementsDouble-Blind MethodGraft vs Host DiseasePilot ProjectsStomatitisTransplantation, Homologous

Stichwörter der Autor:innen

Ascorbic acidBone marrow transplantGraft versus host diseaseOral mucositisVitamin C

Substanzen

AntioxidantsAscorbic AcidVitamins

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. bita.shahrami@gmail.com.
  • Hematology, Oncology, and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran. bita.shahrami@gmail.com.
  • Hematology, Oncology, and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran. srad@sina.tums.ac.ir.
  • Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
  • Hematology, Oncology, and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Heidari, S., Shahrami, B., Rad, S., Sadeghi, K., Sharifi Aliabadi, L., Hadjibabaei, M., & Vaezi, M. (2026). High-dose vitamin C supplementation in patients undergoing allogeneic hematopoietic stem cell transplantation: A pilot randomized, triple-blind, placebo-controlled trial. Supportive Care in Cancer, 34(3). https://doi.org/10.1007/s00520-026-10434-2

Vancouver

Heidari S, Shahrami B, Rad S, Sadeghi K, Sharifi Aliabadi L, Hadjibabaei M, et al. High-dose vitamin C supplementation in patients undergoing allogeneic hematopoietic stem cell transplantation: A pilot randomized, triple-blind, placebo-controlled trial. Supportive Care in Cancer. 2026;34(3). doi:10.1007/s00520-026-10434-2

BibTeX
@article{Heidari2026,
  author = {Heidari, Shima and Shahrami, Bita and Rad, Soroush and Sadeghi, Kourosh and Sharifi Aliabadi, Leyla and Hadjibabaei, Molouk and Vaezi, Mohammad},
  title = {High-dose vitamin C supplementation in patients undergoing allogeneic hematopoietic stem cell transplantation: A pilot randomized, triple-blind, placebo-controlled trial},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {3},
  doi = {10.1007/s00520-026-10434-2}
}
Kostenlos starten →